usvpAdminer, Author at USVP/ - Page 10 of 38

Cleave Therapeutics Licenses First-in-Class VCP/P97 Inhibitor CB-5339 To CASI Pharmaceuticals For Greater China Region

401(k) provider Human Interest doubles valuation with $55M fundraise

ON24 Announces Pricing of Initial Public Offering

Ribon Therapeutics Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries

Quantifind Secures $22 Million Financing Round

Neuros Medical Raises $38.5M in Series BB Funding for Completion of Pivotal Clinical Study for Chronic Post-Amputation Pain

W2O Acquires Swoop and IPM.ai, Fueling New Health Technology Business

Carlsmed Raises $10M to Commercialize Breakthrough aprevo™ Devices

Hunters Receives Growth Funding from Snowflake Ventures for its Open XDR

Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program